Quickly Spot Consensus Among the World’s Best Equity Analysts
| Name | Upside % |
Analysts bullish % |
|
|---|---|---|---|
|
63%
upside
4 price targets
|
0
%
|
|
|
|
63%
upside
4 price targets
|
0
%
|
|
|
|
63%
upside
3 price targets
|
0
%
|
|
|
204
Crinetics Pharmaceuticals
CRNX
$4.28B
|
63%
upside
7 price targets
|
0
%
|
|
|
62%
upside
3 price targets
|
0
%
|
|
|
|
62%
upside
5 price targets
|
0
%
|
|
|
|
62%
upside
6 price targets
|
0
%
|
|
|
|
62%
upside
3 price targets
|
0
%
|
|
|
|
62%
upside
3 price targets
|
0
%
|
|
|
|
62%
upside
3 price targets
|
0
%
|
|
|
211
Edgewise Therapeutics
EWTX
$2.24B
|
61%
upside
4 price targets
|
0
%
|
|
|
61%
upside
9 price targets
|
0
%
|
|
|
|
60%
upside
4 price targets
|
0
%
|
|
|
|
60%
upside
9 price targets
|
0
%
|
|
|
|
60%
upside
8 price targets
|
0
%
|
|
|
|
60%
upside
3 price targets
|
0
%
|
|
|
|
60%
upside
4 price targets
|
0
%
|
|
|
|
59%
upside
3 price targets
|
0
%
|
|
|
|
59%
upside
6 price targets
|
0
%
|
|
|
|
59%
upside
6 price targets
|
0
%
|
|
|
|
58%
upside
5 price targets
|
0
%
|
|
|
|
58%
upside
7 price targets
|
0
%
|
|
|
|
58%
upside
3 price targets
|
0
%
|
|
|
|
58%
upside
6 price targets
|
0
%
|
|
|
|
57%
upside
7 price targets
|
0
%
|
|